Checkpoint Blockade Stumbles in Advanced EGFR-Mutant NSCLC
CHICAGO -- In patients with metastatic EGFR-positive lung cancer who progressed on targeted agents, adding…
Browsing Tag
EGFRMutant
Immunotherapy-Based Regimen Boosts PFS in EGFR-Mutant Lung Cancer
Combining the PD-1 inhibitor sintilimab with a bevacizumab biosimilar and chemotherapy…